Mesenchymal stem cell transplantation ameliorates Sjögren’s syndrome via suppressing IL-12 production by dendritic cells

Abstract Background Mesenchymal stem cells (MSCs) have been demonstrated to be effective in treating autoimmune diseases including Sjögren’s syndrome (SS). We aim to compare the effects of MSC transplantation (MSCT) and the role of serum interleukin-12 (IL-12) in SS. Methods IL-12 levels were measur...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Bingyu Shi, Jingjing Qi, Genhong Yao, Ruihai Feng, Zhuoya Zhang, Dandan Wang, Chen Chen, Xiaojun Tang, Liwei Lu, Wanjun Chen, Lingyun Sun
Формат: Artigo
Язык:Inglês
Опубликовано: BMC 2018-11-01
Серии:Stem Cell Research & Therapy
Предметы:
Mesenchymal stem cells
Sjögren’s syndrome
Interleukin-12
Online-ссылка:http://link.springer.com/article/10.1186/s13287-018-1023-x
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы